Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized mannitol versus 5% hypertonic saline in children with cystic fibrosis
IRCT20180307038994N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of Bronchitol and hypertonic saline in cystic fibrosis (CF) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Pulmonary function based on spirometry. Started Jan 2016; status: completed.
02
Drugs
Bronchitolhypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on IRCT20180307038994N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180307038994N1.